This is a print ad from POM Wonderful that claims that their promegranate juice could reduce blood pressure. This print ad is deemed ethical because it does not state that this product can completely remedy high blood pressure problem. With the headline that states "Decompress" we can clearly understand that this health product can decrease one's blood pressure and ASA can't argue that this ad is abiding the law. The body text mentioned that this health drink helps to guards your body againts variety of health problems. It does not state that it can entirely protect all these illness. Besides that, the body text has also stated the desired amount of consumption in order to achieve the desired result. Therefore, there is no dishonesty in this print ad. As for the visual, it explains the whole idea of the print ad because it shows the blood pressure monitor on the bottle means if you consume this drink, your blood pressure is going to be as low as the drink. This is overall a simple and straightforward ad. In addition of the help of the body text, it also gives audiences more understanding for this product and how it is scientifically proven that it works.
This newly released ad by Save the Children hopes to increase awareness of child labour and improve the legal framework to protect children in Dhaka, Bangladesh. The idea of this ad that shows a child working being framed inside a mirror box that make it looks like being immortalized in a museum, aims to visualize the tagline in the ad "we must make this a thing of the past" is truly a brilliant and very eye catchy idea. This ad definitely lays a leading role in combating child labor by making it in a very creative way, it, increases consumer awareness, pressing companies with child labor in their supply chains to take action, and engaging governments on what they need to do to address the issue. Powerful !
I have choosen a rather different type of advocacy advertising. Here, is a advertisement done by the NYC Health Department to promote healthy eating. Deciding to take the risk, they have chosen a scare approach where the advertisement would make you feel rather uncomfortable especially if you are one of those on going the problem or might be getting into it. Hence, this advertisement would work best on a person that has similar problems and people who enjoy sugar based beverage or food. Here, we have a man that is above the average weight with a amputated leg. Confirming on how he lose the leg was due to diabetes which is commonly caused by intaking too much sugar. Hence, this would make people think a thousand miles feeling scared on whether this same problem will encountered by them. It would take a bigger hit on people that are above average weight or people whom loves sugar. The colors used are rather well portayed as this is a public service announcement, Red and black are usually the color of danger.
Press realise is the fastest way and easiest way to get free publicitiy. Therefore, writing a good press realise is a must for attractive the reader. Firstly, for sure headline is one of the most important thing In every press realise, therefore grab attention with a good headline, make it creative and attractive. Strong headline (for that matter , email subject line when you send out the pitch) will pull in journalist seeking good stories , the headline should be as engaging as it is accurate. Secondly, Get the right point in the first paragraph, every important point should be addressed in the first beginning sentences, and the subsequent paragraphs should be supporting information. Otherwise, GRAMMAR! Make it grammatically flawless, before sending it out, must check carefully since even single mistake can dissuade a reporter from taking you seriously. Make it straight to the point, one page is the best , and two is the maximum, the shorter the better. This will also force you to condense your most salient information into a more readable document , something journalist are always looking for. Lastly is about provide some good quotes, even if there is no, think about it. Say something that can grab people attention and something memorable and personal, if it possible.
This is a corporate ad for Toyota. First what I like in the ad is the picture's association with the ad. Toyota is advertising their 'Toyota Express Maintenance' where customers can get periodic maintenance services done in 60 minutes and assistance by the roadside anytime of the day, whether it be day or night. The picture of a marriage indicates trust, where both spouses can rely on each other in facing any problems. Their headline "Reassurance is knowing that someone that someone is there for you, no matter what" and "Toyota is there for you, for life", further shows Toyota's pitching for quality customer service. They also put in their unique selling point which are "60 minute express maintenance. An unmatched of 3 years or 1,000,000 kms". The color used in the ad is a light shade of brown, making the ad not too dull or too bright. This makes the ad a little better to read than those with bright colors, which when being too bright makes people not read the ad. The fonts used in the ad are also easy to read as they are just in the perfect size for the amount of info written in there. The spacing also helps in the reading of the ad.
A persuasive fundraising letter would start off by whom the letter is written by. A convincing authority that calls for a fundraising will be more credible compared to a normal person. Besides that, providing statistics and charts about needs of your organization on fundraising is going to aggravate your audiences. Instead, choose one impactful story to tell is going to attract your audience on reading your letter and contribute to your organization. Call for action is a very important element to be included in the fundraising letter for the reason that it has to sound emergency and anxious thus audiences will react to it right away.
A reply slip should be included as well. Furthermore, the envelope shouldn't be negelected because it is an important part of the fundraising letter and overall fundraising package. After all, it needs to be designed in such a way that gets the donor to open it. A teaser from a story that will be included or a stamp that reads "Emergency Appeal" will actually attract donors to open them right after they receive the package.
This brochure from Hawes & Co, a real estate agency from the United Kingdom is simple, yet attractive and eye-catching to the viewers. At first glance, people will obviously be attracted by the visual and the vibrant colors. The drawing is so creative and funny in a way because it is a drawing of a person's head in the shape of a house with the headline "Are you thinking about a new home?". The "think" and "home" they implemented in the visual makes it quite cool and in my opinion, it really is a new way to execute the brochure this way rather than just a flat and mundane real estate brochures, which usually only shows a sample of new houses and a number on it. By looking at this brochure, people will feel and have a perception that this company has a good taste and ultimately, encourage them to give the company a call. For viewers to act upon the ad is basically the advertisers' main goal and for them to get contact with the company is what the real estate agents aim to gain. You might be curious why the benefits are not stated there? The truth is that Hawes & Co is famous already in the UK since it was established in 1988. So this brochure is more intended to show that they are the superior company in the UK. Using an art on flyers nowadays is really trending like for concert, party events, etc.


Thin Client PCs, also referred to as "slim" or "lean" clients, are named after their design- all but the most basic components have been removed out and their functions delegated to the server. Ultra-fast gigabit connections, running faster than general PCI Buses and many client hard drives, convey input and output from the client to the server for processing and storage.
Why are Thin Client PCs efficient?
By loading only a user-interface and a networked operating system on each thin client, they are smaller, less expensive per-seat than full computers and require less energy to run. By using server-based services for running office applications and storing data, a few servers can free the strain on many clients, resulting in reduced waste and efficient system management.
Thin client's advantages are continuing to grow: the cost of hardware is falling, but the cost of IT personnel, energy, and waste disposal are rising. With a properly arrayed Thin Infrastructure, you get all of the benefits of a conventional network- centralized data storage, easy data back-up, and security- with easier administration and more efficiency. Combined with Blade Server technology, your network will become a lean, efficient business asset.
Due to the high speed connections of a Thin Network, user experience will be very similar to their experience with "Thick Client" Computers. Power software technologies allow each user to have a dedicated, personal partition on the server known as a Virtual Machine.
With thin technologies, user-experience isn't the major change, energy and expense efficiency is.
To learn more about how Thin Client technologies can help your business, contact us today.


William has an elevated white blood cell count which could mean infection. The blood tests that check for infections take 24 hours to come back. Because of the elevated WBC, he has to be admitted so they can watch him overnight. Going back to the unit he was in for 2+ months, I wonder if his nurses missed him. He's doing OK and Daddy Robert will be staying the night with him. He's such a trooper, this hospital is a second home to him. All he knows is change...I hope we can put a stop to that sooner than later. Keep the prayers coming that this is a quick visit and we get back on the road to going home soon.


text:
Volume: 20 Issue: 11 November 2022
Review of Sarcopenia and Testosterone Deficiency With Chronic Liver Disease and Postoperative Liver Transplant Utility of Short-Term Testosterone Replacement Therapy
Ashokkumar Jain,1 Danielle Haussner,2 Tjasa Hranjec,1 Fauzia Butt,1 Jonathan G. Stine,3 Anita Ankola,4 Hussain Al Yousif,5 Russell Dicristina,5 Karen L. Krok,3 Juan Arenas1
Objectives: Chronic liver disease is often associated with testosterone deficiency. However, testosterone replacement does not improve hepatic function or survival with diseased liver. So far, to our knowledge, testosterone replacement therapy after successful liver transplant for functional sarcopenia has not been studied. We had 3 goals: (1) define postoperative functional sarcopenia after liver transplant with serum testosterone level; (2) examine the role of short-term testosterone replacement therapy with active in-bed exercise of upper and lower extremity joints; and (3) correlate functional sarcopenia with skeletal muscle index and skeletal muscle density in relation to ascites, pleural effusion subtracted body mass index.Materials and Methods: We evaluated 16 liver transplant recipients who had been receiving posttransplant testosterone replacement therapy with functional sarcopenia. Preoperative and postoperative demographics and laboratory and radiological data were retrieved; body mass index, skeletal muscle index, and skeletal muscle density were calculated. For this retrospective study, institutional review board approval was obtained before the electronic database was reviewed and analyzed. Results: Mean testosterone level was 28.3 ng/dL (<5% of expected). Twelve patients received 1 dose, and the remaining 4 patients received >1 dose of testosterone cypionate, 200 mg. Mean hospital stay was 26 days. Seven patients were discharged home, with the remaining patients to a rehabilitation facility or nursing home. One patient died from a cardiac event, and another patient died from recurrent metastatic malignancy. The 1-year and 5-year actuarial patient and graft survival rates were 93.8% and 87.5%, respectively. Overall, 5 patients were sarcopenic by skeletal muscle index, and 6 patients had poor muscle quality by skeletal muscle density. Conclusions: Testosterone deficiency after liver transplant exists with functional sarcopenia. Two-thirds of such recipients have low skeletal muscle index and/or have low skeletal muscle density. Short-term testosterone replacement therapy with in-bed active exercise provides 5-year patient and graft survival of 87.5%.
Key words : Ascites, Body mass index, Cirrhosis, Density, Hydrothorax, Skeletal muscle index
Testosterone is an anabolic steroid that builds muscle mass, muscle strength, and bone density. Testosterone also promotes hematopoiesis and improves insulin resistance, mood, libido, and cognitive function. Testosterone deficiency in male patients with chronic liver disease is associated with greater morbidity and mortality.1,2 Testosterone replacement therapy in patients with chronic liver disease does not improve hepatic function, hepatic histological changes, or survival outcomes; however, it improves gynecomastia, muscle strength, and hemoglobin and also reduces body fat and lowers hemoglobin A1c. After liver transplant (LTx), testosterone deficiency with functional sarcopenia could persist. However, after LTx, the prevalence and severity of testosterone deficiency and the utility of short-term testosterone replacement therapy have so far, to our knowledge, not been studied. The aims of the present study were to (1) define post-LTx functional sarcopenia and examine testos-terone level with clinical functional sarcopenia and utility of post-LTx short-term testosterone replace-ment therapy, (2) review testosterone replacement therapy in chronic liver disease and sarcopenia, and (3) show the correlation of functional sarcopenia with ascites and pleural effusion subtracted (APES) body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) with radiological computed tomography (CT), skeletal muscle index (SMI, calculated as skeletal muscle area in centimeters squared divided by height in meters squared), and skeletal muscle density (SMD).
Institutional review board permission was obtained before the retrospective data collection and analysis were initiated. After institutional review board approval, the retrospective electronic database from June 2014 to June 2017 was searched at our academic LTx center. Sixteen male post-LTx recipients who received testosterone replacement therapy for defined functional sarcopenia were identified. Basic demographics of the study patients, clinical history, postoperative progress, and radiological and labora-tory results were obtained from a secure electronic database. From the last available CT scan before LTx, total skeletal muscle area (SMA) was calculated at the L3 midvertebral level, including the circumferential abdominal wall, psoas, and paraspinal muscle groups. The SMI was calculated from SMA and normalized to patient height in meters squared. The SMD is obtained using threshold values of -29 to +150 Hounsfield units (HU) for muscle tissue on the Aquarius iNtuition software (version 4.4.11, TeraRecon) by experienced radiologists. Cut-off values for SMD to BMI and methodology have been described by Hayashi and colleagues and Fearon and colleagues.3,4 Detail is given in the results section. The patient in case 3 had all CT scans performed at an outside facility; hence, SMI/SMD was not evaluated.
Criteria used for clinical functional sarcopenia after liver transplant
Although there are several different ways to assess functional sarcopenia, most such methods are not applicable or reliable in the immediate post-LTx period.5-8 Post-LTx functional sarcopenia was considered in 2 different scenarios: (1) inability to get out of bed with the support of 2 physiotherapists within 24 hours after extubation and able to stand and (2) ventilator support for more than 2 days after LTx with functional hepatic allograft and without major complications. This was based on an alternative definition of sarcopenia by Delmonico and colleagues, who emphasized the importance of performance of lower extremities.9 This is also in line with the revised definition and diagnosis by the European Working Group on Sarcopenia in Older People (EWGSOP) in 2019, for which greater importance was emphasized with the functional aspect of the muscle, and sarcopenia was recognized as muscle disease or muscle failure.6 Total serum testosterone levels were tested with post-LTx functional sarcopenia. Patients with low serum testosterone concentration, <20% of expected for that age group,10 received intramuscular testosterone replacement therapy (testosterone cypionate, 200 mg). The testosterone dose was repeated after 2 weeks (2 half-lives of testosterone cypionate) if the patient was still hospitalized and the functional sarcopenia had not resolved.
Management of functional sarcopenia with frequent in-bed active exercise
We engaged our providers, in rotation, to visit patients every 2 hours during the daytime, while the patient was awake, to encourage in-bed frequent active participation with flexion and extension exercises of all the joints of upper and lower extremities along with standard incentive spirometry for about 5 to 10 minutes per session.
Correction of ascites and pleural effusion subtracted body mass index with skeletal muscle index and skeletal muscle density
Measured pre-LTx weight was corrected by APES if present. For the ascitic fluid volume measurement, we used an objective 3-dimensional measurement on CT scans including fluid pockets in all 4 quadrants. In addition, when present, pleural effusion was measured and added to the ascitic fluid volume. The total volume of the ascitic fluid and pleural effusion was subtracted from the weight of the patient (1 mL fluid = 1 g of body weight), and the corrected weight and BMI were adjusted. The APES BMI was categorized as underweight (BMI <18.5), normal weight (BMI from ≥18.5 and <25), overweight (BMI from 25 to <30), or obese (BMI ≥30). The APES BMI was correlated with radiological measurements of SMI and SMD for sarcopenia.3,4
All patients were followed until November 2020 by the same team of providers. Values for mean, median, and SD were calculated in Microsoft Excel. Kaplan-Meier survival estimations were calculated in IBM SPSS software (version 26). All recipients were commenced on tacrolimus, mycophenolate mofetil, and steroid-based immunosuppression.11
Between June 2014 and June 2017, 55 male patients received a deceased donor LTx, of which 16 (30.8%) recipients were tested for serum total testosterone levels based on clinical functional sarcopenia. Patient 12 received a combined liver and kidney transplant, and patient 2 had post-LTx pontine myelinolysis (Table 1). For the remaining 39 concurrent male recipients, functional sarcopenia and testosterone levels were not determined. The mean testosterone concentration was 28 ± 19 ng/dL (median, 22; range 10-83 ng/dL) (Table 1), which was 4.8% (median, 3.7 ± 3.8%) of the expected concentrations for age-matched healthy men.10,12
Pretransplant characteristics of the study patients
Pretransplant demographic details of each patient are shown in (Table 1). The mean age at the time of transplant was 56.0 ± 9.3 years. The mean weight was 94.3 ± 18.9 kg; the mean BMI was 32.0 ± 7.4; the Model for End-Stage Liver Disease (MELD) score13 was 33.5 ± 8 (median, 36); and the Child-Pugh score distribution was C15 to C10 for 11 patients, B9 for 2 patients, B8 for 2 patients, and A5 for 1 patient.14 Pre-LTx signs of hepatic decompensation included ascites in 15 patients (94%); of those, 12 (75%) required multiple paracenteses, and 10 (63%) had spontaneous bacterial peritonitis. Five (31%) patients had hepatic hydrothorax, of whom 3 required thoracentesis. Fourteen patients (88%) had hyponatremia, 15 (94%) had encephalopathy, and 11 (69%) had hepatorenal syndrome, 8 of whom required renal replacement therapy. All patients were followed until November 2020; mean post-LTx follow-up was 53.8 ± 13.4 months (median, 51.5; range, 33.2-76.8 months).
Testosterone replacement after liver transplant
All 16 recipients tested received intramuscular testosterone (testosterone cypionate, 200 mg) replacement therapy. Twelve patients (75%) received a single dose of testosterone. Three patients (patients 8, 12, and 13) received a second dose of testosterone injection, 2 weeks apart. Patient 2, who was hospitalized after LTx for 80 days with pontine myelinolysis, received 4 doses of testosterone when the testosterone level fell below <20% of the expected level. Of 4 patients who received >1 dose of testosterone, 3 required tracheostomies for prolonged ventilator dependency (Table 2).
Hospital stays
The overall mean initial post-LTx hospital stay was 26 ± 17 days (median, 22 days). Seven (44%) patients were discharged home, 6 (38%) were sent to a rehabilitation facility, 2 (13%) went to acute rehabilitation, and 1 (6%) was discharged to a skilled nursing home. Patient 2 had pontine myelinolysis, patient 5 had renal failure, and patient 7 had recurrent hepatocellular carcinoma (HCC), all of whom required readmission. None of the patients required readmission for functional sarcopenia alone.
Patient and graft survival
All study patients retained their primary hepatic allograft and did not require retransplant. Hence, patient and graft survival results were the same at all time points. Two patients died during the study; patient 5 died 2 months after LTx at home after discharge from rehabilitation, presumably from a cardiovascular event, and patient 7 died from recurrent metastatic hepatocellular carcinoma 20.5 months after LTx. This provided actuarial 1-year patient and graft survival of 93.8% and 5-year actuarial survival of 87.5% (Figure 1).
Correlation of body mass index with skeletal muscle index and skeletal muscle density
Patients were divided into 4 groups based on APES BMI: underweight (BMI <18.5, n = 2), normal weight (BMI ≥18.5 and <25, n = 2), overweight (BMI ≥25 and <30, n = 6), and obese (BMI ≥30, n = 5). We compared these patient groups with skeletal muscle parameters of SMI and SMD as surrogate markers for skeletal muscle mass and quality to assess sarcopenia (Table 3 and Figure 2).3 For underweight and normal weight conditions, SMI <43 was considered as sarcopenic and SMD <41 was considered poor muscle quality. Sarcopenic values and poor muscle quality values are indicated in (Table 3). For overweight and obese patients, SMI <53 was considered to be a sarcopenic value and SMD <33 HU was considered abnormal muscle quality.3 Both underweight patients had low SMD but were not sarcopenic by SMI. Of 2 normal-weight patients, 1 patient was in the sarcopenic range and 1 patient had low SMD <41 HU. Of the 6 overweight patients, 2 had low SMD <33 HU in poor muscle quality range, whereas all had SMI >53 (nonsarcopenic range). Among the 5 obese patients, 1 patient was sarcopenic (SMI <53) and had low muscle quality (SMD <33 HU). Three other patients were sarcopenic by SMI <53 alone, and 1 patient (case 8) had skeletal muscle parameters within the reference range. Overall, 4 patients were sarcopenic by SMI, 5 patients had poor muscle quality by SMD, and 1 patient was sarcopenic with poor muscle quality and muscle density.
Review of sarcopenia, diagnostic challenges, and implication in cirrhotic patients
Diagnosis of sarcopenia has become more difficult as more components have been added to the definition, including muscle mass, muscle fat, muscle strength, and physical performance. The term sarcopenia was first suggested in 1988 by Rosenberg to define an age-related decline in body muscle mass index that affects functional capacity in older patients.15 With a better understanding of sarcopenia, the definition of sarcopenia has changed in the past 2 decades. In 2010, the EWGSOP5 added fat content and functional capacity aspects to sarcopenia (recognized as sarcopenic obesity). This description was further revised in 2018 (EWGSOP2) to recognize sarcopenia as a muscle disease (muscle failure) and the advised early detection of low muscle quantity and quality.6 Noticeably, the functional aspect of the muscle was given more emphasis in the diagnosis of sarcopenia. Additionally, in 2017, Golse and colleagues retrospectively studied 256 post-LTx recipients to develop an L3 lumbar vertebral SMI for sarcopenia by using the third lumbar vertebral index (L3MSA) measurement of the psoas muscle area at L3 normalized by height and body surface area.7Diagnostic tools and methods, such as the 6-minute walk test and the stair climb power test, could not be utilized for most recipients after LTx. Mid-arm circumference, skinfold thickness, and calf circumference are affected with edema and may be unreliable in obese patients. Often, the term frailty has been used when there is a functional decline in global health without sarcopenia. However, most of these are subjective observations and often difficult to differentiate objectively. Sarcopenia secondary to malnutrition, incurable malignancy, or chronic illness is easily recognized.16-18 Atkins and colleagues alluded to sarcopenic obesity resulting in higher morbidity and mortality from cardiovascular and coronary disease in elderly people.19 The effect of sarcopenia with chronic liver disease has a poor outcome, as it is often associated with frailty and muscle wasting.18,20,21 Sarcopenia with liver disease affects the prognosis and increases morbidity and mortality.8,18 We have incorporated functional sarcopenia impairment for older people by Delmonico and colleagues9 for a postoperative LTx recipient. Recipients who were unable to get out of bed and stand on their feet with the help of 2 physiotherapists within 24 hours of extubation or who were ventilator dependent for more than 2 days post-LTx with a functioning hepatic allograft without any major complications were considered to have functional sarcopenia impairment.
Review of testosterone deficiency and replacement therapy with chronic liver disease
Testosterone deficiency was first studied for patients with Laennec cirrhosis in 1948 by Lloyd and Williams.22 They observed a 71% decrease in libido and potency, 84% of the patients had a decrease in axillary hair 87% and noted testicular atrophy in 70% of patients and gynecomastia in 42% of patients from testosterone deficiency with cirrhosis. Wells reported survival advantages with testosterone therapy for chronic liver disease with prednisolone in 1960.23 Puliyel and colleagues reported that administering testosterone 100 mg intramuscularly on alternate days for 4 weeks resulted in a reduction in ascites and pedal edema with an increase in albumin.24 A double-blind, placebo-controlled, multicenter Copenhagen trial (1986) reported that oral testosterone treatment (200 mg, 3 times per day) improved hemoglobin and decreased gynecomastia without changing hepatic biochemistry.25 Gluud and colleagues conducted a placebo-controlled prospective randomized trial using oral testosterone 300 mg, 3 times per day, without any benefit on liver biopsy after a median follow-up of 30 months.26 Yurci and colleagues found that transdermal testosterone replacement improved muscle strength, ameliorated gynecomastia, and altered body fat distribution in hypogonadal men with cirrhosis.27 Sinclair and colleagues concluded that low-dose testosterone replacement therapy with cirrhosis is safe and increases muscle mass with a reduction in fat mass and improves bone mass, hemoglobin, and hemoglobin A1c without any survival benefits.28 Sinclair and colleagues claimed testosterone deficiency in chronic liver disease has more of an impact on survival outcomes than MELD.29
Testosterone deficiency and replacement therapy
Testosterone replacement therapy for hypogonadism in male patients is a well-established treatment.30-33 Sarcopenia and testosterone deficiency can exist concurrently with chronic liver disease with or without muscle wasting. Testosterone replacement therapy with advanced chronic liver disease was not successful with incurable underlying pathology. However, hepatic replacement resolves the underlying hepatic pathology, and a short-term testosterone replacement therapy with functional sarcopenia has not been studied.34In the present report, we have utilized functional sarcopenia for post-LTx recipients based on impairment of lower extremity for older people by Delmonico and colleagues.9 We have defined it as an inability to get out of bed and stand with the help of 2 physiotherapists within 24 hours of extubation or requirement for prolonged in-bed ventilator depen-dency for more than 2 days post-LTx with a functional hepatic allograft, without major complication. We have described 16 consecutive male post-LTx recipients who received short-term testosterone replacement therapy soon after LTx for functional sarcopenia and extremely low total testosterone serum concentrations (mean <5% of expected).10 Most often a single dose of testosterone cypionate at 200 mg intramuscularly (75% of patients) was adequate. A small proportion of patients (18.75%) received a second dose after 2 weeks, and 1 patient (6.25%) with a prolonged hospital stay received 4 doses during a period of 80 days. In addition, providers in rotation visited the patients every 2 hours during the daytime, to encourage patients' participation in-bed exercises with flexion and extension of all joints of both upper and lower extremities for 5 to 10 minutes per session. Within a day or so, we observed a progressive improvement in mobility. This has been very useful for the confidence-building of patients and their visiting family members and friends. Recently, Falqueto and colleagues in their meta-analysis have alluded to the benefit of combined exercise with short-term anabolic-androgenic steroids for sarcopenia and cachexia atrophy due to inactivity.35
Potential side effects of testosterone administration
Testosterone is an anabolic steroid with several functions in the body besides improving muscle strength in the body. Excessive use is not without negative side effects on the body. Androgen and androgen receptor signaling can initiate carcinogen-related and hepatitis B-related HCC.36-38 Androgen and androgen receptors play a role in HCC and cholangiocarcinoma. Furthermore, testosterone could affect the vascular responsiveness and the vascular reactivity hemostatic system, which is associated with cardiovascular risk.39-41 However, in our present report, we used testosterone as a replacement when the serum testosterone levels were 2% to 16% (mean, 5%) of expected levels. Seventy-five percent of the patients received a single dose. Others received an additional testosterone dose when serum testosterone levels were <20% of expected and while in the hospital under supervision. One patient who died from recurrent HCC at 20 months after transplant had received a single dose of testosterone. His testosterone level was <4% of expected. We do not believe testosterone replacement therapy had any influence on this outcome.
Correlation of sarcopenia with body mass index and radiological findings for skeletal muscle index and skeletal muscle density
Two underweight patients were not sarcopenic by SMI, but both had poor muscle quality by SMD. Of 2 patients with normal body weight, 1 patient was sarcopenic by SMI, and another had low SMD. Of 6 overweight patients, none was sarcopenic by SMI, and 2 patients had poor muscle quality by low SMD. Of the 5 obese patients, 4 were sarcopenic by SMI, of whom 1 also had poor muscle quality by SMD. If we combine underweight, normal-weight, and over-weight patients, of 10 patients, 1 was sarcopenic by SMI (10%), and 5 had poor muscle quality by SMD (50%); in contrast, among 5 obese patients, 3 were sarcopenic by SMI (60%), and 1 was sarcopenic by SMA with poor muscle quality by low SMD (20%).3,4 Sarcopenia was more prevalent in obese patients by SMI, and poor muscle quality was observed more often in underweight patients by low SMD.
Survival outcome
Patient and graft survival rates have improved since 1990 after the introduction of tacrolimus, with overall 5-year patient and graft survival being 71% and 59%, respectively.42 With better management and availability of antiviral and antifungal medications, the survival rates have improved further.43,44 The Scientific Registry of Transplant Recipients (SRTR) showed patient and graft survival rates of 87% and 77% for patients <35 years of age and of 80% and 77% for patients >65 years of age, respectively.45 In the present study population with functional sarcopenia and severe testosterone deficiency, we showed that short-term replacement therapy provided 87.5% patient and graft survival at 5 years. Our selection criteria for functional sarcopenia were more from clinical observations of (1) inability to get out of bed with the support of 2 physiotherapists within 24 hours postextubation and able to stand and (2) ventilator support for more than 2 days post-LTx with functional hepatic allograft and without major complications. This takes into account the description by Delmonico and colleagues of performance of lower extremity9 and recent modifications of EWGSOP 2019 that recognized sarcopenia as muscle disease or muscle failure,6 as described in our Materials and Methods section.Although there are several methods for testos-terone replacement therapy, we preferred the intramuscular route because we expect it to be highly effective (testosterone cypionate, 200 mg), as recommended by the Endocrine Society clinical practice guideline.46We believe that testosterone deficiency after LTx could be more common than previously identified. We did not evaluate all 55 male patients for sarcopenia and testosterone concentration. However, patients with functional sarcopenia according to our current guidelines have more to gain from short-term replacement therapy. Although in the definition of functional sarcopenia we have included "without major complication," these patients could be included as a separate category. Our patient 2 had severe functional sarcopenia from pontine myelinolysis and testosterone deficiency. At the last follow-up, he was alive with good hepatic function. Our proposed definition of post-LTx sarcopenia may be strict; however, it benefits the patients who need it the most. Certainly, more prospective studies with variable dosage and frequency of testosterone, including risks and benefits, would be useful. We have used the intramuscular formulation of testosterone; however, dermal patches of testosterone are available, which could be more suitable in less severe cases.27
Male patients with chronic liver disease and high MELD scores often have functional sarcopenia with or without muscle wasting. Soon after a major surgical LTx procedure, testosterone deficiency persists and functional sarcopenia is difficult to diagnose by conventional criteria.6-8 We have utilized functional sarcopenia based on the lower extremity performance suggested by Delmonico and colleagues9 for older people. Patients with the inability to get out of bed and stand on their feet with the help of 2 physiotherapists within 24 hours of extubation or who are ventilator dependent for more than 2 days post-LTx have benefited from testosterone replacement therapy. Sarcopenia by SMI was more common with obese patients (80%), whereas a rate of poor muscle quality by SMD decreases from underweight (100%) to obese patients (25%). In our experience, a single replacement dose of testosterone cypionate at 200 mg and frequent in-bed active exercises of all upper and lower joints are useful and provide 1-year and 5-year patient and graft survival of 93.8% and 87.5%, respectively. Our present report provided a descriptive, proof-of-concept study. Ideally, further work should include a large population-based prospective trial with well-defined clinical parameters to identify the prevalence. The dosing, frequency, route of administration, risk, and benefit of testosterone replacement therapy for LTx recipients with various degrees of functional sarcopenia could be evaluated. Although we did not include women in the present study, women could also be considered in future studies with the potential side effects of testosterone replacement therapy.
Grossmann M, Hoermann R, Gani L, et al. Low testosterone levels as an independent predictor of mortality in men with chronic liver disease. Clin Endocrinol (Oxf). 2012;77(2):323-328. doi:10.1111/j.1365-2265.2012.04347.x
CrossRef - PubMed
Sinclair M, Gow PJ, Grossmann M, Shannon A, Hoermann R, Angus PW. Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score. Liver Transpl. 2016;22(11):1482-1490. doi:10.1002/lt.24607
Hayashi N, Ando Y, Gyawali B, et al. Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer. Oncol Rep. 2016;35(3):1727-1731. doi:10.3892/or.2015.4475
Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489-495. doi:10.1016/S1470-2045(10)70218-7
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. doi:10.1093/ageing/afq034
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi:10.1093/ageing/afy169
Golse N, Bucur PO, Ciacio O, et al. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation. Liver Transpl. 2017;23(2):143-154. doi:10.1002/lt.24671
Nam NH, Kaido T, Uemoto S. Assessment and significance of sarcopenia in liver transplantation. Clin Transplant. 2019;33(12). doi:10.1111/ctr.13741
Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55(5):769-774. doi:10.1111/j.1532-5415.2007.01140.x
Simon D, Preziosi P, Barrett-Connor E, et al. The influence of aging on plasma sex hormones in men: the Telecom Study. Am J Epidemiol. 1992;135(7):783-791. doi:10.1093/oxfordjournals.aje.a116365
Jain A, Kashyap R, Dodson F, et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation. 2001;72(6):1091-1097. doi:10.1097/00007890-200109270-00019
Mohr BA, Guay AT, O'Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf). 2005;62(1):64-73. doi:10.1111/j.1365-2265.2004.02174.x
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-470. doi:10.1053/jhep.2001.22172
Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology. 2001;33(2):473-475. doi:10.1053/jhep.2001.22481
Rosenberg IH. Summary comments. Am J Clin Nutr. 1989;50(5):1231-1233. doi:10.1093/ajcn/50.5.1231
Carias S, Castellanos AL, Vilchez V, et al. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation. J Gastroenterol Hepatol. 2016;31(3):628-633. doi:10.1111/jgh.13166
Ligibel JA, Schmitz KH, Berger NA. Sarcopenia in aging, obesity, and cancer. Transl Cancer Res. 2020;9(9):5760-5771. doi:10.21037/tcr-2019-eaoc-05
Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014;20(25):8061-8071. doi:10.3748/wjg.v20.i25.8061
Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62(2):253-260. doi:10.1111/jgs.12652
Bhanji RA, Carey EJ, Yang L, Watt KD. The long winding road to transplant: how sarcopenia and debility impact morbidity and mortality on the waitlist. Clin Gastroenterol Hepatol. 2017;15(10):1492-1497. doi:10.1016/j.cgh.2017.04.004
Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, Macias-Rodriguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24(1):122-139. doi:10.1002/lt.24958
Lloyd CW, Williams RH. Endocrine changes associated with Laennec's cirrhosis of the liver. Am J Med. 1948;4(3):315-330. doi:10.1016/0002-9343(48)90248-4
Wells R. Prednisolone and testosterone propionate in cirrhosis of the liver. A controlled trial. Lancet. 1960;2(7166):1416-1419. doi:10.1016/s0140-6736(60)92566-6
Puliyel MM, Vyas GP, Mehta GS. Testosterone in the management of cirrhosis of the liver—a controlled study. Aust N Z J Med. 1977;7(6):17-30.
Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. The Copenhagen Study Group for Liver Diseases. Hepatology. 1986;6(5):807-813.
Gluud C, Christoffersen P, Eriksen J, Wantzin P, Knudsen BB. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis. Am J Gastroenterol. 1987;82(7):660-664.
Yurci A, Yucesoy M, Unluhizarci K, et al. Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis. Clin Res Hepatol Gastroenterol. 2011;35(12):845-854. doi:10.1016/j.clinre.2011.09.005
Sinclair M, Grossmann M, Hoermann R, Angus PW, Gow PJ. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial. J Hepatol. 2016;65(5):906-913. doi:10.1016/j.jhep.2016.06.007
Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: abnormalities and implications. J Gastroenterol Hepatol. 2015;30(2):244-251. doi:10.1111/jgh.12695
Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag. 2009;5(3):427-448. doi:10.2147/tcrm.s3025
Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men: a clinical research center study. J Clin Endocrinol Metab. 1996;81(10):3469-3475. doi:10.1210/jcem.81.10.8855787
Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81(12):4358-4365. doi:10.1210/jcem.81.12.8954042
Wang C, Alexander G, Berman N, et al. Testosterone replacement therapy improves mood in hypogonadal men: a clinical research center study. J Clin Endocrinol Metab. 1996;81(10):3578-3583. doi:10.1210/jcem.81.10.8855804
Jain A, Schreibman KZ, Shah A, et al. Testosterone deficiency a diagnosis to consider: in adult male post liver transplant (LTx) recipients with failure to thrive, muscle wasting or sarcopenia is observed. Transplantation. 2016;100(7):S552.
Falqueto H, Junior JLR, Silverio MNO, Farias JCH, Schoenfeld BJ, Manfredi LH. Can conditions of skeletal muscle loss be improved by combining exercise with anabolic-androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions. Rev Endocr Metab Disord. 2021;22(2):161-178. doi:10.1007/s11154-021-09634-4
Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer. 2014;21(3):R165-R182. doi:10.1530/ERC-13-0283
Farazi PA, DePinho RA. The genetic and environmental basis of hepatocellular carcinoma. Discov Med. 2006;6(35):182-186.
Yeh SH, Chen PJ. Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology. 2010;78 Suppl 1:172-179. doi:10.1159/000315247
Smith EB. Haemostatic factors and atherogenesis. Atherosclerosis. 1996;124(2):137-143. doi:10.1016/0021-9150(96)05837-6
Busse R, Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res. 1996;33(3):181-194. doi:10.1159/000159147
Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol. 1997;20(5):426-432. doi:10.1002/clc.4960200505
Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg. 2000;232(4):490-500. doi:10.1097/00000658-200010000-00004
Eid AJ, Razonable RR. New developments in the management of cytomegalovirus infection after solid organ transplantation. Drugs. 2010;70(8):965-981. doi:10.2165/10898540-000000000-00000
Fung JJ. Fungal infection in liver transplantation. Transpl Infect Dis. 2002;4 Suppl 3:18-23. doi:10.1034/j.1399-3062.4.s3.3.x
Health Resources and Services Administration. OPTN/SRTR 2019 Annual Data Report: Liver. https://srtr.transplant.hrsa.gov/annual_reports/2019/Liver.aspx#LI_tx_adult_GF_all_C_b64
Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. doi:10.1210/jc.2009-2
Pages : 1000 - 1008
DOI : 10.6002/ect.2022.0132
PDF VIEW [1080] KB. FULL PDF VIEW
From the 1Division of Transplantation, Department of Surgery, Pennsylvania State University, College of Medicine, Hershey Medical Center, Hershey, Pennsylvania; the 2Department of Emergency Medicine, New York-Presbyterian Hospital, Cornell University and Columbia University, New York, New York; the 3Division of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State University, College of Medicine, Hershey, Pennsylvania; the 4Department of Radiology, North Shore University Hospital, Northwell Health, Manhasset, New York; and the 5Department of Radiology, Pennsylvania State University, College of Medicine, Hershey Medical Center, Hershey, Pennsylvania, USA
Acknowledgements: For advice in drafting the manuscript, we thank Eileen Swartz and Stalin Campos, from the Division of Transplantation, Department of Surgery, Pennsylvania State University, College of Medicine, Hershey Medical Center, and Thomas R. Riley III and Ian Schreibman, from the Division of Gastroenterology and Hepatology, Department of Medicine, Pennsylvania State University, College of Medicine. The authors have not received any funding or grants in support of the presented research or for the preparation of this work and have no declarations of potential conflicts of interest.
Author contributions: AJ, TH, FB, and JA are transplant surgeons who verified patients' presurgical and postsurgical course. AA, HAY, and RD are radiologists who evaluated the radiological aspects. DH collected and cross-checked the data. JGS and KLK are transplant hepatologists who managed the patients' pretransplant treatment and long-term posttransplant follow-up. All the coauthors have read the manuscript and contributed with editing and language.
Corresponding author: Ashokkumar B. Jain, Pennsylvania State University, College of Medicine, Department of Surgery, Division of Transplant Surgery, 500 University Drive, PO Box 850, MC H062, Hershey, PA 17033, USA
E-mail: ajain1@pennstatehealth.psu.edu
Table 1. Pretransplant Characteristics
Figure 1. Long-Term Rates of Patient Survival and Graft Survival
Table 2. Postoperative Course and Discharge Status
Table 3. Correlation of Body Mass Index With Skeletal Muscle Index and Skeletal Muscle Density for Sarcopenia
Figure 2. Correlation of Body Mass Index With Skeletal Muscle Index and Skeletal Muscle Density for Sarcopenia and Poor Muscle Quality

redpajama_set_name: RedPajamaCommonCrawl


text:
Q: exec inside package does not call callback function If I use the following code in a different file it does not call the callback function of exec. It does work if I execute the code in the main file.
inConsole.js
var exec = require('child_process').exec;
var log = require('../includes/log');

var errorCodes = {
        30: "inEnterprise returned an error",
        40: "Unable to connect to host",
        41: "Unable to resolve hostname",
        42: "Unable to create socket",
        43: "Invalid port number",
        44: "Connect timeout",
        45: "Error sending message",
        46: "Server response timeout",
        47: "Unspecified read error",
        49: "Undefined socket error",
        50: "Invalid login information",
        57: "Invalid API version",
        51: "Contact attempts cannot exceed 99",
        52: "Contact cycle delay cannot exceed 9999",
        53: "Text device delay too large",
        54: "Invalid notification ID",
        55: "Invalid notification title",
        56: "No device or no text specified"
}

exports.post = function(req, res) {

    if(!('notification' in req.body)) {
        res.send({status: 'error', error: "notification parameter missing"});
        return;
    }

    if(req.body.notification == '') {
        res.send({status: 'error', error: "notification parameter is empty"});
        return;
    }

    if(!('message' in req.body)) {
        res.send({status: 'error', error: "message parameter missing"});
        return;
    }

    if(req.body.message == '') {
        res.send({status: 'error', error: "notification parameter is empty"});
        return;
    }

    var cmd = '/usr/local/bin/inConsole -I -i "' + req.body.notification + '" -X "' + req.body.message + '"';

    log.write_to_log("REQUEST");
    log.write_to_log(req.body);

    console.log("command: " + cmd)

    exec(cmd, function(err, stdout, stderr) {
        console.log('exec command')
        var status = {};
        if(err) {
            if(err.code in errorCodes) {
                status = {status: 'error', errorCode: err.code, errorText: errorCodes[err.code]};
            } else {
                status = {status: 'error', errorCode: err.code, errorText: "Unknown error occured"};
            }
        } else {
            var response = stdout.replace(/^(?=\n)$|^\s*|\s*$|\n\n+/gm,"").split('\n');
            status = {status: 'successful', reportId: response[response.length - 1] };
        }

        log.write_to_log("RESPONSE");
        log.write_to_log(status);
        res.send(status);
    })
}

The first console.log works but the second inside the callback does not output.
main.js
#!/usr/bin/env node

var express = require('/usr/lib/node_modules/express');
var app = express();

var site = require('./routes/site');
var samba = require('./routes/samba');
var inConsole = require('./routes/inConsole');

app.configure(function() {
    app.use(express.json());
    app.use(express.urlencoded());
    app.use(app.router);
    app.use(express.errorHandler({ dumpExceptions: true, showStack: true}));
});

// Site Routes
app.get('/', site.index);

// Samba Routes
app.get('/samba', samba.list);
app.post('/samba', samba.post);

// inConsole Routes
app.post('/inConsole', inConsole.post);

// Start server
var server = app.listen(2000, function() {
    var host = server.address().address
    var port = server.address().port
    console.log("API Server listening at http://%s:%s", host, port)
});

No clue why this does not work..

redpajama_set_name: RedPajamaStackExchange


text:
Home Our Magazine's Overflow
Lake's School Resource Deputies And K9 Max Work Straight Through The Summer
by Marilyn M. Aciego, LLN Editor-in-Chief
in Our Magazine's Overflow
[PHOTO CREDIT: Lake County Sheriff's Office]
[Original Publish Date: 06/30/20]
From August to May each school year, Lake County Sheriff's Office school resource deputies (SRDs) are in Lake County public schools protecting children and keeping the schools safe, but what are they doing during the summer?
Master Deputy Tim McCaig and his K9 partner Max are riding the streets of Lake County helping the patrol unit and nosing around for illegal narcotics, McCaig told Lake Legal News Friday; most often, they back up other deputies upon request.
Max is a single-purpose passive K9, which means he does not bite and chase people, he just sniffs out drugs. During the school year, Max travels all around the county with McCaig: "I spend the week traveling between the middle schools and high schools," he tells LLN, "My goal is to hit every school once a week." Max sniffs lockers, vehicles and backpacks when needed, and most students are excited to see him, McCaig says.
Max is trained to sniff out cocaine, methamphetamine, heroin and marijuana, McCaig explains. The most common drug found in the schools is marijuana, notes SRD Lt. Christie Mysinger. Earlier this month, Max had an exciting find — 4 grams of methamphetamine, a drug not commonly found in the schools. For his effort, Max is rewarded with praise and his toy, McCaig tells LLN. "He does his job to get his reward."
While Max is the only K9 SRD; there are 31 humans in the SRD unit. They are helping in a variety of positions at LCSO, including patrol, civil/warrants, corrections, sex offender checks and they provide security and traffic assistance for the Department of Health (DOH) COVID-19 testing sites, Mysinger says.
"During the summer we assist the intel unit with verifying that sex offenders live where they say they live and drive what they say they drive. Protecting our children doesn't stop because school is out," Mysinger explains when interviewed.
Each summer, the SRDs normally put on two weeklong summer camps, one on the north side of the county and one on the south side of the county, for children aged 8 through 18. This year, they were forced to cancel the camps due to COVID-19, which enabled the SRDs to assist with COVID-19 testing sites, Mysinger says. "Due to the high volume of residents wishing to be tested the SRD unit assists the DOH with traffic and security at its testing sites. COVID-19 has affected the entire community, we are glad to help where we can."
Our Editor-in-Chief, Marilyn M. Aciego, began writing for Lake Legal News in 2010. Born and raised in Lake County, she is a graduate of Umatilla High School and Lake-Sumter State College. She started her journalism career at LSSC, where she was editor of both student publications, The Angler and The Odyssey. Her professional career began at the Daily Commercial in 2004 where she covered cops and courts the majority of her time there until she left in 2009. Currently, along with being Editor-in-Chief of Lake Legal News, she is the Florida bureau chief for an international media organization. She has made more than two dozen appearances on live national television, including Nancy Grace and the Greta Van Susteren show, along with her appearance on Evil Twins. Contact her with breaking news, tips, and feedback by sending an e-mail to 352Tips@gmail.com. You can also contact us on our Facebook page — and make sure you "Like" and "Follow us" there. [PHOTO CREDIT: Bonnie Whicher]
Share350TweetSend
Leesburg Police: Loaded Revolver With Removed Serial Numbers Is Given To Young Boy — By His Convicted-Felon Father
Saying Goodbye After 24 Years, Eustis Police Captain Shane McSheehy Leaves To Become Iowa Small-Town Chief
Marilyn M. Aciego, LLN Editor-in-Chief
Lake County Inmates Help With Dire "Around The Clock" Need For COVID-19 Masks
Meet A Public Information Officer: Lauren Brown
Social Media Shows The Lighter Side Of Lake County Law Enforcement
The Nuts And Bolts Of The Bail Bond Business
OPINION: "OBSTRUCTION BY DISGUISE" ARREST IS NOT LOOKING SO PRETTY


text:
Preview: New York Giants at Cincinnati Bengals, August 22, 2019
Eli Manning – © USA TODAY Sports
Follow @BigBlueInteract
Preseason Game Preview: New York Giants at Cincinnati Bengals, August 22, 2019
THE STORYLINE:
Aside from Golden Tate's suspension, Sterling Shepard's broken thumb, Sam Beal's nagging hamstring, and George Asafo-Adjei's concussion, this has been a relatively positive summer for the Giants. The team is relatively healthy (knock on wood), the offensive line is coming together, the receivers are being more productive than expected, the quarterbacks are playing well, and there are positive signs from a number of the young players on the defensive side of the football. Yes, there are concerns about the pass rush and cohesion on defense. And whether the coaches, media, and fans want to admit it or not, there is a full-fledged quarterback controversy/transition on the horizon. But the overall sense is the team is finally headed in the right direction.
THE INJURY REPORT:
The following players are not likely to play on Thursday night:
WR Golden Tate (concussion)
WR Sterling Shepard (thumb)
OT George Asafo-Adjei (concussion)
LB Alec Ogletree (calf)
CB Deandre Baker (knee)
CB Antonio Hamilton (groin)
CB Sam Beal (hamstring)
NEW YORK GIANTS ON OFFENSE:
Yes, it's only the preseason, and yes, opposing teams have played their back-ups more than their starters. But the Giants have scored 63 points in their first two games without Saquon Barkley and Evan Engram. This is after the Giants averaged over 27 points per game during the second half of the 2018 season. The Pat Shurmur-Mike Shula offense is becoming accustomed to scoring points. One wonders how productive this team will be once Barkley is running behind perhaps the team's best offensive line since Tom Coughlin was winning Super Bowls.
Eli Manning looked sharp on his only drive against the Bears' second-team defense last week. He probably will see a bit more action this week but it doesn't sound like Pat Shurmur intends for him to play past halftime (and he may pull him far sooner than that). We all know Manning became shell-shocked behind the inept offensive lines the team has field for the past seven years. Most quarterbacks don't recover from that. We still need to see Eli consistently stand tough in the pocket and deliver accurate throws down-the-field in clutch situations when teams are coming after him. He's got a competent offensive line in front of him now and the best running back he has ever played with (apologies to Tiki Barber, Brandon Jacobs, and Ahmad Bradshaw).
For better or worse, Pat Shurmur has decided to put Barkley and Engram in bubble wrap this preseason. If either is going to play, it will be this game. If not, see you on opening day. Again, not to beat a dead horse, but we really haven't seen this offense at full-strength yet this preseason. Yet, they are still scoring 30 points per game.
It's scary how similar Eli Manning and Daniel Jones are. Physically, they are roughly the same size. Both have boyish, "aw shucks" faces. They have similar temperaments and are equally adept at handling the press. And unfortunately, we are learning that both seem unfairly targeted for criticism by national media, fans, and other players around the league. Eli still gets mocked despite wearing two legitimage Super Bowl MVP rings and now Jones is fair game despite what he's done in the preseason. I guess we're going to have a cumulative 30-year span where Giants fans will have to tell these people to fuck off. If Jones ends up wearing a ring or two as well, so much the better.
What impressed me the most last week about Jones was not ability to come off his original target and his continued pin-point accuracy, but the fact that he didn't get flustered after his two fumbles. Veteran quarterbacks often struggle to rebound from that kind of adversity. Jones doesn't have Eli's arm (especially a 23-year old Eli). But his accuracy appears superior. And we still haven't seen his wheels yet. Again, Jones is going to have his ups-and-downs. This isn't Madden. There is a learning curve. But the arrow is definitely pointing up, and if I were a fan of another team in the NFC East, I wouldn't be too happy with what I've seen so far.
There has been one major surprise on this side of the football: a group of castoffs seem to be doing just fine at wide receiver. The supposed front-line players, Golden Tate and Sterling Shepard, haven't been the ones making plays, but Bennie Fowler, T.J. Jones, Cody Latimer, Russell Shepard, and Alonzo Russell. It's tough to see this group being this productive once they face starting-caliber cornerbacks for 60 minutes. But maybe, just maybe, these guys can do the job better than we thought? The game against the Bengals is another test.
Another area that has surprised are the back-ups on the offensive line. Heading into camp, the second-team offensive line looked like trouble. And if you said that Chad Wheeler, Brian Mihalik, and George Asafo-Adjei were going to miss significant time, you would have been even more pessimistic. But Nick Gates, Chad Slade, and the others have been pleasant surprises. Good job by the coaching staff and these players. It looks like Asafo-Adjei 's rookie season is going to be a washout. I would like to get a good view of Mihalik, who was the second-string tackle before he missed time with a burner.
I think it's pretty safe to assume that Barkley is the #1 back and Gallman is the #2. Gallman hasn't seen a lot of action this preseason as the coaches have taken a long look at the rest of the backs. Pat Shurmur was effusive in his praise of Eli Penny this week. It still would not shock me if the Giants only carry three backs (one being Penny) or if they do want another true halfback, that guy is not on the roster yet.
At tight end, don't discount Garrett Dickerson. In the competition against C.J. Conrad, he has appeared to be the better receiver. That said, despite his lack of classic size, Conrad looks like the better blocker. If I were Scott Simonson, I would not feel safe.
NEW YORK GIANTS ON DEFENSE:
The first-team defense has not impressed early in both preseason games, settling down after the initial drive. They need to start off stronger. The run defense hasn't been bad, but it should be stronger than it has been as well. I do wonder if the Giants are playing Dexter Lawrence out of position, but it's still very early.
The good news is that some of the guys who need to come through in the pass rush department picked up sacks last week: Markus Golden, Oshane Ximines, and Olsen Pierre. I also saw flashes from Lorenzo Carter, including a nifty spin move that left his opponent grabbing for jersey. (That said, Carter also lost contain on an outside run). Stating the obvious again, so much depends on the pass rush.
Even though he is supposedly recovering well, we probably won't see Alec Ogletree again this preseason. That will prove more opportunities for Tae Davis, Ryan Connelly, Nate Stupar, B.J. Goodson, and Jonathan Anderson. One gets the sense that Goodson very much is fighting for a roster spot.
Although none of the injuries are serious or long-term, the secondary is a bit undermanned right now. Starting corner Deandre Baker will miss his second game. The man he beat out for the job, Sam Beal, hasn't played all preseason. The guy who filled in for both, Antonio Hamilton, is also now out. This will be a good chance for Corey Ballentine to impress, but again, expect inconsistent play and growing pains. Those fans suggesting the team should cut Beal should keep in mind how injuries can turn what looks like a strong unit into something else very quickly. Beal may very well be needed in October and November.
At safety, keep an eye on Kenny Ladler, another no-name who keeps making plays.
NEW YORK GIANTS ON SPECIAL TEAMS:
I'm still personally stunned at the Aldrick Rosas story. So far, 2018 doesn't look like a fluke. On the flip side, the Bears gave me punter envy last week. And the Giants obviously are not too happy either, having claimed a punter off of waivers. Lost in the shuffle too was that Zak DeOssie (toe injury) didn't long snap, Taybor Pepper did. I don't think Zak's job is at risk, but Zak isn't going to play forever.
I had been viewing T.J. Jones as a reliable but unspectacular punt returner until his muffed punt against the Bears. I still wonder who will be returning punts against the Cowboys? Will they have Jabrill Peppers do it?
Corey Ballentine is being given a chance to win the kickoff return job, but on opening day, would the coaches prefer the security of having a veteran do it such as Cody Latimer or T.J. Jones?
FROM THE COACH'S MOUTH:
Head Coach Pat Shurmur on what he wants to see from his defense in this game: "I think they have to make sure they're over-exaggerating their communication, being in all of the right spots, playing with the right leverage. Upfront, when the other team is throwing the ball, we have to be disruptive and get pressure on the quarterback."
THE FINAL WORD:
Coaches normally don't play their starters much in the preseason finale. This is probably the last good look we'll have at many starters before the games count. In less than a week and a half, the Giants need to make at least 37 roster moves.
Articles, Game Previews and Reviews Tagged with: 2019 New York Giants, Cincinnati Bengals
August 20, 2019 New York Giants Training Camp Report Preseason Game Review: New York Giants 25 – Cincinnati Bengals 23
Forum Post: Joe Schoen really wants the Giants GM position
Forum Post: 2nd interview for Poles
Forum Post: Schoen getting 2nd interview
Forum Post: Duggan has article on NYG dysfunction.


The Narayana Suktam is, often thought of as the mystical appendix to the Purusa Suktam. While the Purusa Suktam presents the Supreme Being as an All-encompassing, Impersonal Purusa, the Narayana Suktam honours Narayana, a very personal and accessible Lord. The Narayana Suktam is a devout, touching, emotional and personal address to the Creator and sustainer of the universe. The chant also presents that the divine is residing deep in our hearts, and all we need to do is acknowledge his presence and connect with our hearts to access his grace.
Pavamanasuktam is a very famous chant from the Vedic tradition. It is often chanted to help clean/refine energy be it in a place or a person. Many times when entering a new house or space of work, this chant was recited to purify the space of its past energy so that a new positive beginning could be commenced.
It is also used in healing, when dark energy such as past traumas, abuses or impressions from abuse/violence needs to be transformed.
Both Listening and learning to chant this chant can be very helpful in a number of circumstances.


text:
Aug 2, 2017 May 24, 2018 David Meyer
WELCOME to Connected Rights, your home on the range of digital rights news and analysis.
APPLE HAS SCRUBBED DOZENS OF VPN APPS from its Chinese App Store. Virtual private networks (VPNs) allow people to re-reroute their online activities in a way that makes it hard to tell where they are, and to read things that are blocked if they access the internet normally. The Chinese government doesn't like them, and requires providers to have special licenses. So Apple has kicked out the unlicensed VPN apps: http://bbc.in/2vkz5ai
Apple's full statement: "Earlier this year China's [IT ministry] announced that all developers offering VPNs must obtain a license from the government. We have been required to remove some VPN apps in China that do not meet the new regulations. These apps remain available in all other markets where they do business."
Well, Apple could have refused, which would probably have doomed the iPhone in China. As Apple fan John Gruber has noted, this would deprive Chinese people of Apple's encrypted communications services, which haven't yet been nixed like WhatsApp has: http://bit.ly/2vfzTg7. Gruber ultimately blames Apple's app-distribution model for the mess, writing: "They'd rather deal with the negative consequences of the App Store as a choke point than give up the benefits (including the profits) of maintaining complete control over all software on the platform."
Apple CEO Tim Cook also weighed in yesterday, saying: "We would obviously rather not remove the apps, but like we do in other countries, we follow the law wherever we do business… We strongly believe in participating in markets and bringing benefits to customers is the best interest of the folks there and in other countries as well." http://for.tn/2uiRSxJ
OK, but… this was not a good decision. VPNs are good for most people, apart from those who want to control people. This was a decision that will leave a lot of people less safe, regardless of how good Apple's own communications apps are. As ExpressVPN, one of the affected providers, wrote, Apple's call will "threaten free speech and civil liberties": http://bit.ly/2uSghOn. This is a company choosing money over what's right, whichever way you spin it.
Meanwhile, Vladimir Putin has signed a Russian law that also bans VPNs and other tools that people can use to get past censorship and surveillance.
NSA whistleblower Edward Snowden is sheltering in Moscow under Russian asylum, but that didn't stop him sounding off over the new law(s). "Whether enacted by China, Russia, or anyone else, we must be clear this is not a reasonable 'regulation,' but a violation of human rights," he thundered over Twitter, also calling the Russian law a "tragedy of policy". My story: http://zd.net/2tW5bFa
If you'd like to support the creation of this newsletter and help me develop further Connected Rights resources, please check out my new Patreon page.
MORE ENCRYPTION FACE-PALMERY, this time courtesy of British home secretary Amber Rudd, who is still determined to get around the fact that encryption only works at all if it works for everyone. Rudd said the British government supports strong encryption and wouldn't ban it, but would also like companies to stop using it: http://bit.ly/2u1cC1D
The idea that end-to-end encryption stops people from snooping on conversations "might be true in theory", the not-a-mathematician wrote, but "real people often prefer ease of use and a multitude of features to perfect, unbreakable security… who uses WhatsApp because it is end-to-end encrypted, rather than because it is an incredibly user-friendly and cheap way of staying in touch with friends and family?"
Rudd sounds very much like someone who's enthusiastically grasping the wrong end of the stick. The tension between security and usability is a real thing and, until the aftermath of the Snowden revelations, there weren't many options for staying secure in a super-user-friendly way. But now there are. WhatsApp's encryption, for example, doesn't come at the expense of usability – you don't even have to think about it to use it. There's no longer anything to be gained from being less secure. This ship has sailed.
WhatsApp owner Facebook still thinks strong encryption is swell, of course. Chief operating officer Sheryl Sandberg has a pitch for law enforcement agencies for giving up their crackdown quest: "The message itself is encrypted, but the metadata is not. If people move off those encrypted applications to other applications offshore, the government has less information, not more." http://bit.ly/2f4TBoE
REMEMBER WHEN THE ROOMBA COMPANY said it wanted to sell maps of people's homes to the highest bidder (it wasn't long ago: http://bit.ly/2hlf90E)? Well, iRobot now says it will "never sell your data". "Information that is shared needs to be controlled by the customer and not as a data asset of a corporation to exploit," it said: http://zd.net/2tQ6hpL.
As for the idea that it wanted to sell mapping data derived from the robotic vacuum cleaners, this was "a misinterpretation". Indeed, the original Reuters story that kicked off this fuss has now been changed to replace "sell maps" with "share maps for free with customer consent": http://reut.rs/2uWjdcX
If you'd like to hire me to write articles about digital rights issues, speak at your event or provide advice for your business, drop me an email at david@dmeyer.eu.
GERMAN RESEARCHERS POSED as a marketing company in order to get the "anonymous" browsing histories of over three million German citizens, which they received for free from a data broker.
The researchers – a journalist and a data scientist – were able to de-anonymise many of the people involved, reportedly learning of "a judge's porn preferences and the medication used by a German MP": http://bit.ly/2uTOonk. As the Guardian article says, the identification can come from web addresses (URLs) that have people's usernames in them, or by correlating as few as 10 URLs.
There are two things to take away from this. Firstly, the data broker industry is a shadowy morass that really should become a regulatory target at some point soon – our information goes all over the place and we have no way to even know what's happening, let alone stop it. Secondly, "anonymising" data is sometimes not simple. If it's possible to retrace your steps by matching up the many fragments of your activities, you're exposed.
GOOGLE'S YOUTUBE CLAIMS THAT ITS ALGORITHMS are "in many cases" better than humans at flagging videos that need to be taken down for their extremist or terrorism-related content, thanks to advances in machine learning technology: http://bit.ly/2hjCP5F
That's interesting, because Google's senior director for European public policy, Nicklas Lundblad, said not long ago that the technology wasn't ready yet. "Is it possible within the existing computer science knowledge to build a system that can automatically do content regulation and decide that this little piece of content here is hate speech and this little piece of content over here should stay up?" Lundblad asked at the re:publica conference in Berlin in May.
"I think that we are still far, far away from being able to do that. I think that the notion of context and the ability to detect context is very hard. It's an open computer science problem." http://bit.ly/2hmC242
A MASSIVE DRUG CASE IN AUSTRALIA has collapsed because the police agency involved refused to tell anyone – even the court – how its surveillance techniques work. Judges called the police and prosecutors' actions "difficult to understand": http://bit.ly/2uWACjC
Tagged Algorithms, Amber Rudd, Anonymity, Apple, Australia, Censorship, China, Data protection, Edward Snowden, Encryption, Facebook, Germany, Hate speech, Roomba, Russia, Surveillance, UK, Vladimir Putin, VPNs, WhatsApp
EU Court kicks mass surveillance yet again
Blocking the internet's memory? A reason would be nice


text:
Bouchard Suing USTA
41 - 60 of 1578 Posts
First 3 of 79
~Poseidon~ said:
Sometimes I really ask myself, what the hell happend with this world.
In my world, you fall, you stand up and 2 weeks later you laugh about how stupid and how unlucky you were that day...
A concussion is a very serious injury, not something you can laugh away.
She lost $100,000 just in bonus pool money because of alleged negligence of someone else, of course she is suing. Everybody would do that, including you, if you were in a similar situation.
Reactions: New-Era
Riskiick
pov said:
Yeah. That will work against her. She chose to walk through a darkened room already shut down for the day rather than go find someone.
I think it might work for her. If she was just wandering around without anyone's knowledge then it would likely be just her fault. But since they were aware that she wanted an ice bath and that going through the training room was the only way she could get there, then leaving the room pitch black with a slippery floor maybe wasn't the best way of looking out for her safety.
Reactions: ML1452 and bluwaters
bluwaters
PatsyStone said:
That would be weird, cause there was someone to whom she requested this ice bath and someone who had prepared it.
IKR?
There's a big question mark over that.
When did athletes have access?
If if the locker room was shut down for the night, how did Genie get in?
Was an ice bath prepared for her?
Where was the staff?
I've got a lot of questions!
No doubt the USTA will claim some kind of negligence on Bouchard's part.
It's hard to imagine they want the bad publicity from a suit like this though.
I have read that Genie's father is very litigious and sued another party over some aspect of her career in the past.
The athletes should have a safe environment during tournaments.
I absolutely support that.
It seems that during a Grand Slam 24 hour access to the facilities is not unreasonable.
Some matches go late into the night, some players want to get an early start to their practices, warm ups, and treatments.
Reactions: Perun
~Poseidon~
wolf79 said:
that works only if you weren't suffering severe injury like a concussion by that fall.
That's the unlucky part, isn't it?
Sometimes you're just at the wrong place at the wrong time in your life. You slip in a dark room where you expect an Ice Bath, I mean come on, that's already enough, to at least blame yourself in parts. And then? Do you really need to discuss, who is "guiltier"?
Shit happens sometimes, it obviously happend that night.
But of course, the lawsuit might have a simple reason, that is not called cash grabbing: Health insurance refusing to pay the cost for the accident.
I mean...
Reactions: Pancha
gold fangs
You wouldn't be saying that if you fell, incurred a serious injury and were unable to earn money for an indefinite period of time. Nothing to do with a litigious society and everything to do with protecting people - from wealthy athletes to ordinary people - against negligence. That's why you'll see warning signs in any public bathroom that's just been cleaned.
I wonder how the law would work if Bouchard's concussion has long-term effects. As it stands, her potential lost earnings are relatively small, but if it's the worst case scenario à la Borwell...
-NAJ-
USTA should hire Genie's biggest hater on TF for their lawyer
Eugenie Bouchard files suit against the US Tennis Association, after the concussion incident at the US Open
https://ca.sports.yahoo.com/blogs/e...ussion-incident-at-the-us-open-221659826.html
Eugenie Bouchard filed suit Wednesday in US District Court, a civil action against the US Tennis Association in the wake of her accident in the locker room at the US Open last month.
Two counts of negligence are cited, along with a request for a jury trial.
No specific monetary compensation is mentioned beyond the fact that the amount requested exceeds $75,000 US.
But Bouchard's attorneys are asking for actual, compensatory and statutory damages, punitive damages "as allowed by law", pre and post-judgment interest, injuctive relief, attorneys' fees, taxable costs and "any and all further relief as this court deems just and proper."
****More to come ...***
KournikovaFan91 said:
I'm not a fan of her's but I support her 100% in this case. We can not have a Grand Slam event being run in such a haphazard manner resulting in concussion.
So, she fell because the floor was wet in the locker room where people often shower? How surprising. Do they need to warm you a floor might be wet there every time you enter? This is probably the most idiotic thing I have ever heard. Girl, you fell because you were clumsy, take responsibility and deal with it.
Reactions: Perun, Adrian. and CPH
Just Do It said:
Riskiick said:
then leaving the room pitch black with a slippery floor maybe wasn't the best way of looking out for her safety.
I doubt very much that person she asked for an ice-bath knew of those conditions. On noticing it the thing is to go find someone and say "Hey the lights are off, is it okay to go in?" OR IMO if not then it's on you.
"These lifeforms feel such passionate hatreds over matters of custom, God concepts, even - strangely enough - economic systems." - Capt. J Piccard USS Enterprise
I've been saying a while I certainly expected her to sue the USTA. Wasn't expecting it to be filed so quickly. Didn't Lauren Davis's suit not get filed until a year after she was injured?
Post number 7.
Reading is overrated and exhausting, much easier to just skim through headlines.
Wintermute said:
Years later, I think, because she continued to suffer from the injuries she got there.
TERRASTAR18
bluwaters said:
I thought the different parties were negotiating a settlement.
I don't know what Genie is seeking as far as damages but one thing should happen as a result of this suit.
Players' health, safety, and security must always be properly provided during tournaments.
For some reason, the USTA failed to do so and Bouchard suffered injury as a result.
This should not have happened and hopefully won't ever happen again.
she didn't turn on a light and used equipment w/o trained staff.
JustSayDet
Rodzilla said:
lolol as a result of the fall her rankings have dropped and is likely to continue to drop
thats funny
They're serious
***********************
Jameka the G.O.A.T
MrProdigy555;27947754 said:
*inserts a couple fingers into you*
Reactions: chef-d'œuvre
I'm afraid if it comes to the question of how well she would have done in the singles, that pasting she took from Vinci in New Haven is going to get trotted out.
The rules are changed, It's not the same, It's all new players in a whole new ball game
- Donald Fagen, "The Goodbye Look"
or turn on a light....
Ban Boy
The amount has been updated to greater than $150,000US now.
Marta Kostyuk, Félix Auger-Aliassime, Fedex, The Stanimal, Naomi Osaka, The Dog Dolgopolov, Petr Korda, The Borg, Ana Ivanovic
and, of course, her majesty, la reine
STEFFI GRAF
Viktymise Mar 21, 2019


text:
Take a flavour journey through Africa
The Africa Café had the humble beginnings of a dream in a South Africa that had yet to transform into the democracy and icon of freedom that it is today.
Portia and Jason De Smidt had no formal training in food preparation, but armed with creative flair and abundant passion they were determined to open South Africa's first African restaurant. Their idea was not warmly received by the business community and without much needed financial backing the only option was to open the doors of their small home in the Bohemian suburb of Observatory. They were determined to fill a gap in the market and create food that would celebrate Africa's diversity and rich tapestry of tastes and aromas. There was very much a sense that Africa, through years of oppression, had lost pride in its heritage, and this inspired the dynamic couple even more to challenge and change negative perceptions of what this vast and great continent had to offer.
Portia's brother, Hector, came down from Johannesburg to complete the team and brought with him extensive marketing expertise to help boost the growth process. Needless to say the word spread and over a period of 15 years the fledgling restaurant grew from strength to strength in the face of much adversity into the much-loved and very popular destination it is today. The Africa Café serves an experience which appeals to tastes from Moscow to Rio. The entertainment value of this experience lies in the beauty of not only our food, but our décor, our people and our hospitality.
"Armed with creative flair and abundant passion they were determined to open South Africa's first African restaurant."
Our amazing
The Africa Café
Escape on a magical journey of culinary delights across the majestic African continent. Sample the flavours of Africa with our delicious tapas menu, or enjoy a feast with the Africa Cafe set menu.
Most of our dishes are vegan and vegetarian. We also cater for dairy, nut and gluten allergies, simply let us know.
The Africa Cookbook
PORTIA MBAU, founder of The Africa Café Photographed and compiled by LUMAI DE SMIDT
Journey through Africa with chef and founder of The Africa Café, Portia Mbau. In 1992 Portia started the first African restaurant in South Africa, serving food inspired by her travels across the continent. The Africa Cookbook is a compilation of her tried-and-tested recipes, designed to bring the flavours and techniques of Africa into your home kitchen. With Portia's added flair, the dishes go beyond tradition into innovation. Part of her signature is the use of healthy and organic ingredients that still evoke the authentic, much-loved flavours of Africa.
Buy One Now!
108 Shortmarket Street, Cape Town, 8001, South Africa
Email: africafe@iafrica.com
© Copyright 2015 The Africa Café All Rights Reserved | Website Development


text:
<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="configuration.xsl"?>
<!--

-->

<configuration>
   <property>
		<name>hbase.rootdir</name>
		<value>hdfs://localhost:8020/hbase</value>
   </property>
   <property>
		<name>hbase.regionserver.ipc.address</name>
		<value>0.0.0.0</value>
   </property >
   <property>
      <name>hbase.zookeeper.quorum</name>
      <value>localhost:2181</value>
   </property>
   <property>
      <name>hbase.cluster.distributed</name>
      <value>true</value>
   </property>

	<property>
	    <name>hbase.security.authentication</name>
	    <value>kerberos</value>
	</property>
	<property>
	     <name>hbase.rpc.engine</name>
	     <value>org.apache.hadoop.hbase.ipc.SecureRpcEngine</value>
	</property>

	<property>
	  <name>hbase.regionserver.kerberos.principal</name>
	  <value>hbase/localhost@EXAMPLE.COM</value>
	</property>

	<property>
	  <name>hbase.regionserver.keytab.file</name>
	  <value>/etc/hadoop/conf/hbase.keytab</value>
	</property>

	<property>
	  <name>hbase.master.kerberos.principal</name>
	  <value>hbase/localhost@EXAMPLE.COM</value>
	</property>

	<property>
		<name>hbase.master.keytab.file</name>
		<value>/etc/hadoop/conf/hbase.keytab</value>
	</property>
	<property>
		<name>hbase.master.wait.on.regionservers.maxtostart</name>
		<value>1</value>
	</property>
	<property>
		<name>hbase.rootdir.perms</name>
		<value>711</value>
	</property>

<property>
  <name>hbase.regionserver.hlog.syncer.count</name>
  <value>1</value>
</property>
<property>
  <name>hbase.regionserver.wal.disruptor.event.count</name>
  <value>16</value>
</property>
<property>
  <name>hbase.hstore.flusher.count</name>
  <value>1</value>
</property>
<property>
  <name>hbase.rest.threads.min</name>
  <value>1</value>
</property>
<property>
  <name>hbase.thrift.minWorkerThreads</name>
  <value>1</value>
</property>
<property>
  <name>hbase.http.min.threads</name>
  <value>1</value>
</property>
<property>
  <name>hbase.regionserver.handler.count</name>
  <value>2</value>
</property>
<property>
  <name>hbase.regionserver.metahandler.count</name>
  <value>1</value>
</property>
<property>
  <name>hbase.regionserver.replication.handler.count</name>
  <value>1</value>
</property>
<property>
  <name>hbase.master.handler.count</name>
  <value>2</value>
</property>

</configuration>

redpajama_set_name: RedPajamaGithub


My grandson wrote the rest of this blog including the poem about plecos.
Most catfish like dark hiding spots. Tunnels or caves like the one in the picture above work well for these nocturnal fish who like to be in the dark. We believe that Gilda laid eggs in this cave and Whiskers, the responsible dad, is guarding them until they hatch.
last. A crab appears and they swim away fast.
Plecos are scavengers and it's not uncommon to see their large mouths sucking algae from the sides of the tank. They are bottom feeders, but they also like plant food, so from time to time I feed them some zucchini and you can see the nibbled-at zucchini treat hanging from a string in the fish tank.
Taking responsibility for a large fish habitat takes a lot of time and care. The water must be kept clean and that means changing it 25% at a time to not shock the fish. It's important to keep daily records of their environment: the water temperature daily (73-81 degrees is ideal), and maintaining a 7.5 pH, and O chlorine content.
It's a rewarding job. Now the plecos recognize me. At feeding time they come to the side of the tank when I come near, and I can hand feed them. It's their personal "thank you" for taking good care of them.


text:
Ibieta Named September Athlete of the Month
Justin Ibieta Named September Athlete of the Month
NEW ORLEANS (October 11, 2018) – Justin Ibieta, a junior quarterback for Country Day, has been selected as the Greater New Orleans Amateur Athlete of the Month for September. Monthly award-winners are chosen in voting by the Greater New Orleans Sports Award Selection Committee, sponsored by the Allstate Sugar Bowl.
Ibieta led the Cajuns to a perfect 4-0 month of September (they are currently 6-0 overall). The junior quarterback completed 73-of-110 (66.4%) of his passes for 994 yards and 12 touchdowns with two interceptions. He also ran 56 times for 408 yards (7.2 yards per carry) and four touchdowns. Ibieta helped the Cajuns to a pair of upset wins – one over top-ranked Amite and one over highly-regarded St. Charles Catholic. Country Day finished the month ranked second in the state in the CrescentCitySports.com Class 2A rankings.
Ibieta was selected from an outstanding group of candidates, including two other high school football standouts, a pair of college football players, two volleyball stars and a golfer.
Martin Butcher from Newman and T.J Finley from Ponchatoula were the other prep football nominees. Butcher threw for 1,088 yards and 18 touchdowns with just one interception for a Newman squad which went 4-0 while Finley led the metro area with 1,626 passing yards to go with 17 touchdown tosses.
The college football stars were Chase Fourcade from Nicholls and Anthony "Pooka" Williams from Kansas. Fourcade led the Colonels to a 3-2 record and the No. 12 national ranking in the FCS. He now ranks second all-time in passing yards at Nicholls. Williams, a Hahnville High graduate, missed the season-opener, a loss to Nicholls, but made his collegiate debut with 125 yards in a win over Central Michigan. He was the Big 12's leading rusher for the first month of the season.
On the volleyball court, Maddie Huekels recorded four triple-doubles (kills, assists and digs) for the Loyola women's volleyball team and was among the national leaders in service aces while Ellie Holzman keyed Mount Carmel Academy's 21-1 record in September by recording 264 kills with a .476 hitting percentage.
Finally, UNO men's golfer Grayson Gilbert, a freshman from Monroe, La., won the individual championship in his first collegiate competition on September 10.
John Sudsbury2018-10-11T14:02:53-05:00


As with its new collections, the Ofélia team travels around Europe and North America to experience and share its favourite looks and locations of choice.
In the shadow of the Louvre's arcades in Paris, the Café Marly has over time become a must for us – chockfull of unforgettable images and encounters. Revisiting Paris, discovering the new Anne Fontaine collection, soaking in the day at the Marly while enjoying a simple, but fully mastered menu: total bliss, simply put.
Luxury, leisure, delight. In a nutshell, that's what Cerisio 7 evokes, from its superb vantage point overlooking mythical Milan. Here in panoramic mode, two pools, one bar and one breathtaking view of Milan's skyline. An Aperol Spritz in hand, a head full of ideas to bring back to the boutiques, friendly conversations and a menu brimming with the flavours of Italy round out this fabulous tableau.
This exhibition space has become a global benchmark. The Fondazione Prada, designed by architect Rem Koolhaas, delivers an overall experience that is both harmonious and complex. Unveiled in the spring of 2018, the glass and white concrete-made Torre tower consists of nine levels, topped by a terrace that features a bar. Discovering a city's spirit by way of contemporary art enriches our travels.
The Mélisse restaurant is an Old Montreal gem. Ideal for every occasion, from a coffee between friends to a morning meeting. It's also the healthy option for a business lunch or the idle pleasures of a happy hour that extends into the night. The cuisine, just like the wine list, is impeccable. One of the city's most gorgeous spaces, which quickly became the Ofélia team's unofficial headquarters.


Horikawa Plastic Battery Operated Robot - Smoking Engine Robot Produced by SH Horikawa (Japan) in the late 1960's. There are two chrome ports above the piston area that would have blown smoke rings. Dimensions The robot has a length of 5.3 inches (13.25cm), width of 4 inches (10cm) and a height of 10 inches (24cm). The box has a length of 10.7 inches (25.5cm), width of 6.5 inches (16.5cm) and a height of 4.3 inches (10.75cm). Condition The box has a few creases on the edges and a small tear towards the top but is in otherwise good condition.
The robot is in good condition. The robot lights up but does not smoke or move.. For further details and conditions see pictures.
The item "Horikawa Plastic Battery Operated Robot Smoking Engine Robot (With Box)" is in sale since Monday, January 30, 2012. This item is in the category "Toys & Games\Vintage & Classic Toys\Robots & Space Toys".